百洋医药(301015.SZ)：拟使用不超5.5亿元暂时闲置募集资金临时补充流动资金

Group 1 - The company, Baiyang Pharmaceutical (301015.SZ), announced the convening of its third board meeting and the third supervisory board meeting on August 14, 2025 [1] - The board approved a proposal to use part of the temporarily idle raised funds to supplement working capital, with a maximum amount of 550 million yuan [1] - The usage period for these funds is set to not exceed 12 months from the date of board approval [1]